Quinolinyl-Thienyl Chalcones as Monoamine Oxidase Inhibitors and their in Silico Modeling Studies

Medicinal Chemistry

Volumn 11, Issue 6, 2015, Pages 580-589

  Zaib, Sumera ^a   Rizvi, Syed Umar Farooq ^b   Aslam, Sana ^b,c   Ahmad, Matloob ^d   Abid, Syed Mobasher Ali ^a   Al Rashida, Mariya ^e   Iqbal, Jamshed ^a  

^a COMSATS Institute of Information Technology ^*  (Pakistan)

^b UNIVERSITY OF THE PUNJAB   (Pakistan)

^c GOVERNMENT COLLEGE WOMEN UNIVERSITY   (Pakistan)

^d GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

^e FORMAN CHRISTIAN COLLEGE A CHARTERED UNIVERSITY   (Pakistan)

Author keywords

Aging; molecular modelling; monoamine oxidase; neurodegenerative disease; quinolinyl thienyl chalcones

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CHALCONE DERIVATIVE; MONOAMINE OXIDASE INHIBITOR; AMINE OXIDASE (FLAVIN CONTAINING); MONOAMINE OXIDASE A, HUMAN; QUINOLINYL-THIENYL CHALCONE;

ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME INHIBITION; HUMAN; IC50; MOLECULAR DOCKING; MOLECULAR MODEL; PRIORITY JOURNAL; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; DOSE RESPONSE; METABOLISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

CHALCONES; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MODELS, MOLECULAR; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84938585218     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/1573406410666141226131252     Document Type: Article

References (46)

1. Azarifar, D.; Ghasemnejad, H. Microwave-Assisted synthesis of some 3,5-arylated 2-pyrazolines. Molecules, 2003, 8(8), 642-648
2. Lévai, A. Synthesis of chlorinated 3,5-diaryl-2-pyrazolines by the reaction of chlorochalcones with hydrazines. Arkivoc, 2005, 9, 344-352
3. Varga, L.; Nagy, T.; Kövesdi, I.; Benet-Buchholz, J.; Dormán, G.; Ürge, L.; Darvas, F. Solution-phase parallel synthesis of 4,6-diarylpyrimidine-2-ylamines and 2-amino-5,5-disubstituted-3,5-dihydroimidazol-4-ones via a rearrangement. Tetrahedron, 2003, 59(5), 655-662
4. Himani, N.C.; Jyotsna, S.M.; Ramakanth, P.; Venkateshwarlu, J. Synthesis, characterization and antibacterial activity of some new 3-(aryl)-1-(4-(quinolin-8-ylamino)phenyl)prop-2-en-1-one. Der. Pharm. Chem., 2010, 2(3), 294-300
5. Lin, Y.M.; Zhou, Y.; Flavin, M.T.; Zhou, L.M.; Nie, W.; Chen, F.C. Chalcones and flavonoids as anti-Tuberculosis agents. Bioorg. Med. Chem., 2002, 10(8), 2795-2802
6. Bhat, B.A.; Dhar, K.L.; Puri, S.C.; Saxena, A.K.; Shanmugavel, M.; Qazi, G.N. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents. Bioorg. Med. Chem. Lett., 2005, 15(12), 3177-3180
7. Go, M.L.; Wu, X.; Liu, X.L. Chalcones: an update on cytotoxic and chemoprotective properties. Curr. Med. Chem., 2005, 12(4), 483-499
8. Nowakowska, Z. A review of anti-infective and anti-inflammatory chalcones. Eur. J. Med. Chem., 2007, 42(2), 125-137
9. Mukherjee, S.; Kumar, V.; Prasad, A.K.; Raj, H.G.; Brakhe, M.E.; Olsen, C.E.; Jain, S.C.; Parmar, V.P. Synthetic and biological activity evaluation studies on novel 1,3-diarylpropenones. Bioorg. Med. Chem., 2001, 9(2), 337-339
10. Arty, I.S.; Timmerman, H.; Samhoedi, M.; Sastrohami, Sugiyanto, Van Der Goot, H. Synthesis of benzylideneacetophenones and their inhibition of lipid peroxidation. Eur. J. Med. Chem., 2000, 35(4), 449-457
11. Narender, T.; Shweta, Tanvir, K.; Rao, M.S.; Srivastava, K.; Puri, S.K. Prenylated chalcones isolated from Crotalaria genus inhibits in vitro growth of the human malaria parasite Plasmodium falciparum. Bioorg. Med. Chem. Lett., 2005, 15(10), 2453-2455
12. Liu, M.; Wilairat, P.; Croft, S.L.; Tan, A.L.; Go, M. Structureactivity relationships of antileishmanial and antimalarial chalcones. Bioorg. Med. Chem., 2003, 11(13), 2729-2738
13. Wu, X.; Wilairat, P.; Go, M. Antimalarial activity of ferrocenyl chalcones. Bioorg. Med. Chem. Lett., 2002, 12(17), 2299-2302
14. Ram, V.J.; Saxena, A.S.; Srivastava, S.; Chandra, S. Oxygenated chalcones and bischalcones as potential antimalarial agents. Bioorg. Med. Chem. Lett., 2000, 10(19), 2159-2161
15. Sivakumar, P.M.; Geetha Babu, S.K.; Mukesh, D. QSAR studies on chalcones and flavonoids as anti-tuberculosis agents using genetic function approximation (GFA) method. Chem. Pharm. Bull., 2007, 55(1), 44-49
16. Viana, G.S.; Bandeira, M.A.; Matos, F. Analgesic and antiinflamatory effects of chalcones isolated from Myracrodrum urundeiva. J. Phytomedicine, 2003, 10(2-3), 189-195
17. Xia, Y.; Yang, Z.Y.; Xia, P.; Bastow, K.F.; Nakanishi, Y.; Lee, K.H. Antitumor agents. Part 202: novel 2'-amino chalcones: design, synthesis and biological evaluation. Bioorg. Med. Chem. Lett., 2000, 10(8), 699-701
18. Epifano, F.; Genovese, S.; Menghini, L.; Curini, M. Chemistry and pharmacology of oxyprenylated secondary plant metabolites. Phytochemistry, 2007, 68(7), 939-953
19. Trivedi, J.C.; Bariwal, J.B.; Upadhyay, K.D.; Naliapara,Y.T.; Joshi, S.K.; Pannecouque, C.C.; Clercq, E.D.; Shah, A.K. Improved and rapid synthesis of new coumarinyl chalcone derivatives and their antiviral activity. Tetrahedron Lett., 2007, 48, 8472-8474
20. Wu, J.H.; Wang, X.H.; Yi, Y.H.; Lee, K.H. Anti-AIDS agents 54. A potent anti-HIV chalcone and flavonoids from genus Desmos. Bioorg. Med. Chem. Lett., 2003, 13(10), 1813-1815
21. Hermoso, A.; Jiménez, I.A.; Mamani, Z.A.; Bazzocchi, I.L.; Piñero, A.G.; Valladares, B. Antileishmanial activities of dihydrochalcones from piper elongatum and synthetic related compounds. Structural requirements for activity. Bioorg. Med. Chem., 2003, 11(18), 3975-3980
22. Sahu, N.P.; Pal, C.; Mandal, N.B.; Banerjee, S.; Raha, M.; Kundu, A.P.; Basu, A.; Ghosh, M.; Roy, K.; Bandyopadhyay, S. Synthesis of a novel quinoline derivative, 2-(2-methylquinolin-4-ylamino)-Nphenylacetamide-a potential antileishmanial agent. Bioorg. Med. Chem., 2002, 10(6), 1687-1693
23. Mokle, S.S.; Sayeed, M.A.; Kothawar, Chopde, Synthesis and Antimicrobial. Activity of some chalcone derivatives. Int. J. Chem. Sci., 2004, 2(1), 96-100
24. Azad, M.; Munawar, M.A.; Siddiqui, H.L. Antimicrobial activity and synthesis of quinoline-based chalcones. J. Appl. Sci., 2007, 7(17), 2485-2489
25. Domínguez, J.N.; Charris, J.E.; Lobo, G.; Domínguez, N.G.; Moreno, M.M.; Riggione, F.; Sanchez, E.; Olson, J.; Rosenthal, P.J. Synthesis of quinolinyl chalcones and evaluation of their antimalarial activity. Eur. J. Med. Chem., 2001, 36(6), 555-560
26. Finberg, J.P. Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release. Pharmacol Ther., 2014, 143(2), 133-152
27. Legoabe, L.J.; Petzer, A.; Petzer, J.P. -Tetralone derivatives as inhibitors of monoamine oxidase. Bioorg. Med. Chem. Lett., 2014, 24(12), 2758-2763
28. Shih, J.C.; Thompson, R.F. Monoamine oxidase in neuropsychiatry and behavior. Am. J. Hum. Genet., 1999, 65(3), 593-598
29. Youdim, M.B.H.; Edmondson, D.; Tipton, K.F. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci., 2006, 7(4), 295-309
30. Riederer, P.; Danielczyk, W.; Grünblatt, E. Monoamine oxidase-B inhibition in Alzheimer's disease. Neurotoxicology, 2004, 25(1-2), 271-277
31. Pizzinat, N.; Copin, N.; Vindis, C.; Parini, A.; Cambon, C. Reactive oxygen species production by monoamine oxidases in intact cells. Naunyn Schmiedebergs Arch. Pharmacol., 1999, 359(5), 428-431
32. Kristal, B.S.; Conway, A.D.; Brown, A.M.; Jain, J.C.; Ulluci, P.A.; Li, S.W.; Burke, W.J. Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. Free Radic. Biol. Med., 2001, 30(8), 924-931
33. Novaroli, L.; Reist, M.; Favre, E.; Carotti, A.; Catto, M.; Carrupt, P.A. Human recombinant monoamine oxidase B as reliable and efficient enzyme source for inhibitor screening. Bioorg. Med. Chem., 2005, 13(22), 6212-6217
34. Castagnoli, N.Jr.; Petzer, J.P.; Steyn, S.; Castagnoli, K.; Chen, J.; Schwarzschild, M.A.; Van der Schyf, C.J. Monoamine oxidase B inhibition and neuroprotection: studies on selective adenosine A2A receptor antagonists. Neurology, 2003, 61(11), S62-S68
35. Magyar, K.; Szende, B. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties. Neurotoxicol., 2004, 25(1-2), 233-242
36. Diermen, V.D.; Marston, A.; Bravo, J.; Reist, M.; Carrupt, P.-A.; Hostettmann, K. Monoamine oxidase inhibition by Rhodiola rosea L. roots. J. Ethnopharmacol., 2009, 122(2), 397-401
37. Rizvi, S.U.F.; Siddiqui, H.L.; Parvez, M.; Ahmad, M.; Siddiqui, W.A.; Yasinzai, M.M. Antimicrobial and Antileishmanial Studies of Novel (2E)-3-(2-Chloro-6-methyl/methoxyquinolin-3-yl)-1-(Aryl)prop-2-en-1-ones. Chem. Pharm.Bull., 2010, 58(3), 301-306
38. Rizvi, S.U.F.; Siddiqui, H.L.; Ahmad, M.N.; Ahmad, M.; Bukhari, M.H. Novel quinolyl-thienyl chalcones and their 2-pyrazoline derivatives with diverse substitution pattern as antileishmanial agents against Leishmania major. Med. Chem. Res., 2012, 21, 1322-1333
39. Novaroli, L.; Reist, M.; Favre, E.; Carotti, A.; Catto, M.; Carrupt, P.A. Human recombinant monoamine oxidase B as reliable and efficient enzyme source for inhibitor screening. Bioorg. Med. Chem., 2005, 13(22), 6212-6217
40. Trott, O.; Olson, A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem., 2010, 31(2), 455-461
41. Son, S.Y.; Ma, J.; Kondou, Y.; Yoshimura, M.; Yamashita, E.; Tsukihara, T. Structure of human monoamine oxidase A at 2.2-A resolution: the control of opening the entry for substrates/inhibitors. Proc. Natl. Acad. Sci. USA, 2008, 105(15), 5739-44
42. Binda, C.; Wang, J.; Pisani, L.; Caccia, C.; Carotti, A.; Salvati, P.; Edmondson, D.E.; Mattevi, A. Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J. Med. Chem., 2007, 50(23), 5848-52
43. Wang, J.; Wang, W.; Kollman, P.A.; Case, D.A. Automatic atom type and bond type perception in molecular mechanical calculations. J. Mol. Graph. Model., 2006, 25(2), 247-60
44. Dunbrack, R.L.Jr. Rotamer libraries in the 21st century. Curr. Opin. Struct. Biol., 2002, 12(4), 431-440
45. Accelrys Software Inc., Discovery Studio Modeling Environment, Release 4.0, San Diego, CA: Accelrys Software Inc.; 2013
46. Meth-Cohn, O.; Rhouati, S.; Tarnowski, B.; Robinson, A. A versatile new synthesis of quinolines and related fused pyridines. Part 8. Conversion of anilides into 3-substituted quinolines and into quinoxalines. J. Chem. Soc., Perkin Trans.1, 1981, 1537-1543.